Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today
announced that its portfolio company, Agripharm Corp., has received its outdoor
cultivation license from Health Canada. According to the update, Agripharm will
use award-winning genetics to grow its first outdoor crop this summer at its
Creemore, Ontario location. “We are pleased to see Agripharm diversify its
operations and increase its growing capacity with the grant of this outdoor
cultivation license,” Canopy Rivers COO Oliver Dufourmantelle said in the news
release. “Agripharm’s outdoor production is ahead of the curve with support
from Green House Brands, which provides decades of experience in choosing, and
successfully growing, the best genetics for open-air crops.”
To view the full press release, visit http://ibn.fm/Mmjxf
About Canopy Rivers
Canopy Rivers is a unique investment and operating platform
structured to pursue investment opportunities in the emerging global cannabis
sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED)
(NYSE: CGC) to identify strategic counterparties seeking financial and/or
operating support. Canopy Rivers has developed an investment ecosystem of
complementary cannabis operating companies that represent various segments of
the value chain across the emerging cannabis sector. As the portfolio continues
to develop, constituents will be provided with opportunities to work with
Canopy Growth and collaborate among themselves, which Canopy Rivers believes
will maximize value for its shareholders and foster an environment of
innovation, synergy and value creation for the entire ecosystem. For more
information, visit the company’s website at www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates
relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
